The pharmaceutical community is abuzz about the new drug, a dual-action therapy showing significant benefits in early studies . This new compound, a incretin activator alongside a GIP compound, appears to notably reduce body size and improve metabolic health . Experts are proposing that it could offer a significant improvement for individuals fa… Read More